Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-13

Clinical Trial Update: Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) [Phase 2]

View source ↗

Summary

Phase 2 trial of LUM-201 in children with Growth Hormone Deficiency has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUM-201

Snippet

Sponsor: Lumos Pharma | Conditions: Growth Hormone Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2026-04-13